|
|
|
RESEARCH PAPERS
2024
38. Maruf AA, Meagan H, Wondrasek A, Fryza A, Leong C, Kowalec K & Bousman CA. (2024). Knowledge of and Perceptions Toward Pharmacogenomics among Pharmacists in Manitoba, Canada. Pharmacogenomics. PubMed ID: 38506345.
37. Wondrasek A, Fryza A, Aziz MA, Leong C, Kowalec K, Maruf AA. (2024). Knowledge, Perceptions, and Attitudes toward Pharmacogenomics among Pharmacists and Pharmacy Students: A Systematic Review. Health Science Reports. 7(1): e1844. PubMed ID:10809028.
36. Gerlach S, Maruf AA, Shaheen S-M, McCloud R, Heintz M, McAusland L, Arnold PD & Bousman CA. (2024). Effect of CYP2D6 Genetic Variation on Patient-Reported Symptom Improvement and Side Effects among Children and Adolescents Treated with Amphetamines. Pharmacogenetics and Genomics. PubMed ID: 38517706.
35. McAusland L, Burton CL, Bagnell A, Boylan K, Hatchard T, Lingley-Pottie P, Maruf AA, McGrath P, Newton AS, Rowa K, Schachar RJ, Shaheen S-M, Stewart S, Arnold PD, Crosbie J, Mattheisen M, Soreni N, Stewart SE & Meier S (2024). The genetic architecture of youth anxiety: a study protocol. BMC Psychiatry. 24(1):159. PubMed ID:38395805.
34. Bharthi K, Zuberi R, Maruf AA, Shaheen S-M, McCloud R, Heintz M, McAusland L, Arnold PD & Bousman CA. (2024). Impact of Cytochrome P450 Genetic Variation on Patient-reported Symptom Improvement and Side Effects among Children and Adolescents Treated with Fluoxetine. Journal of Child and Adolescent Psychopharmacology. 34(1):21-27. Pubmed ID: 38377520.
2023
33. Maruf AA & Aziz MA. (2023). The Potential Roles of Pharmacists in the Clinical Implementation of Pharmacogenomics. Pharmacy (Basel). 11(6): 180. PubMed ID: 37987390.
32. Jafrin S, Aziz MA, Sajal M, Akter T, Das C, Akter T, Hussain MS, Millat MS, Uddin MS, Naznin NE, Reza MS, Maruf AA, Baeesa SS, Ashraf GM & Islam MS. (2023). ZNF804A intronic variant rs1344706 and NGRN rs12807809 genetic polymorphisms and risk of schizophrenia in Bangladesh. Human Gene. 36: 201175. Link.
31. Bousman CA, Maruf AA, Marques DF, Brown LC, Mueller DJ. (2023). Emergence, Implementation, and Future Growth of Pharmacogenomics in Psychiatry: A Narrative Review. Psychological Medicine, Sep 29;1-11. PubMed ID: 37772416.
30. Mostaid MS, Aziz MA, Maisha JA, Islam MS & Maruf AA. (2023). A Review of Pharmacogenetic Studies in the Bangladeshi Population. Drug Metabolism and Personalized Therapy, 38(2):123–131. PubMed ID: 36854045.
2022
29. Brown LC, Stanton JD, Bharthi k, Maruf AA, Müller DJ & Bousman CA. (2022). Pharmacogenomic Testing and Depressive Symptom Remission: A Systematic Review and Meta-Analysis of Prospective, Controlled Clinical Trials. Clinical Pharmacology & Therapeutics, 112(6):1303–1317. PubMed ID: 36111494.
28. Maruf AA & Bousman CA. (2022). Approaches and Hurdles of Implementing Pharmacogenetic Testing in Mental Health Care. Psychiatry and Clinical Neurosciences Reports. 1(2):e26. Pubmed ID: 38868642.
2021
27. Jessel CD, Maruf AA, Oomen A, Arnold PD & Bousman CA. (2021). Pharmacogenetic Testing Knowledge and Attitudes among Pediatric Psychiatrists and Pediatricians in Alberta, Canada. The Journal of the Canadian Academy of Child and Adolescent Psychiatry. 31(1):18-27. PubMed ID: 35251193.
26. Stein K, Maruf AA, Müller DJ, Bishop JR & Bousman CA. (2021). Serotonin Transporter Genetic Variation and Antidepressant Response and Tolerability: A Systematic Review and Meta-Analysis. Journal of Personalized Medicine. 11(12), 1334. PubMed ID: 34945806.
25. Maruf AA, Poweleit EAB, Brown LC, Strawn JR & Bousman CA. (2021). Systematic Review and Meta-Analysis of L-methylfolate Augmentation in Depressive Disorders. Pharmacospychiatry, 55(3):139-147. PubMed ID: 34794190.
2020
24. Maruf AA, Stein K, Arnold PD, Aitchison K, Müller DJ & Bousman C. (2020). CYP2D6 and Antipsychotic Treatment Outcomes in Children and Youth: A Systematic Review. Journal of Child and Adolescent Psychopharmacology. 31(1):33-45. PubMed ID: 33074724.
23. Liu C, Maruf AA & Bousman C. (2020). Reporting of Clozapine-Induced Gastrointestinal Hypomotility and Factors Associated with Fatal Outcomes in Canada. Psychiatry Research. 290:113048. PubMed ID: 32474068.
22. Maruf AA, Fan M, Arnold PD, Müller DJ, Aitchison K & Bousman C. (2020). Reply to Dawes and Colleagues. Canadian Journal of Psychiatry. PubMed ID: 32425056.
21. Maruf AA, Fan M, Arnold P, Müller DJ, Aitchison K & Bousman C. (2020). Review of Pharmacogenetic Testing Options Relevant to Psychiatry in Canada. Canadian Journal of Psychiatry. Feb 17:706743720904820. PubMed ID: 32064906.
2019
20. Maruf AA, Greenslade A, Arnold PD & Bousman C. (2019). Antidepressant Pharmacogenetics in Children and Adolescent: A Systematic Review. Journal of Affective Disorder. 254:98-108. *Co-first author. PubMed ID: 31112844.
19. Bousman CA, Maruf AA & Müller DJ. (2019). Towards The Integration of Pharmacogenetics in Psychiatry: A Minimum, Evidence-Based Genetic Testing Panel. Current Opinion in Psychiatry, 32(1):7-15. PubMed ID: 30299306.
2010 - 2018
18. Maruf AA, O’Brien PJ, Naserzadeh P, Fathian R, Salimi A & Pourahmad J. (2018). Methotrexate Induced Mitochondrial Injury and Cytochrome C Release in Rat Liver Hepatocytes. Drug and Chemical Toxicology, 16:1-11. Pubmed ID: 28298149.
17. Zhang T, Mu Y, Yang M, Maruf AA, Li Pi, Li C, Dai S, Lu J & Dong Q. (2017). (+)-Catechin Prevents Methylglyoxal-Induced Mitochondrial Dysfunction and Apoptosis in EA.hy926 Cells. Archives Of Physiology and Biochemistry, 22:1-7. PubMed ID: 28005432.
16. Maruf AA, Lip H, Wong H & O’Brien PJ. (2015). Protective Effects of Ferulic Acid and Related Polyphenols against Glyoxal- or Methylglyoxal-Induced Cytotoxicity and Oxidative Stress in Isolated Rat Hepatocytes. Chemico-Biological Interactions, 234:96-104. PubMed ID: 255446858.
15. Ng CS, Hasnat A, Maruf AA, Ahmed MU, Pirmohamed M, Day CP, Aithal GP & Daly AK. (2014). N-acetyltransferase 2 (NAT2) Genotype as a Risk Factor for Development of Drug-Induced Liver Injury Relating to Antituberculosis Drug Treatment in a Mixed-Ethnicity Patient Group. European Journal of Clinical Pharmacology, 70(9):1079-86. PubMed ID: 24888881.
14. Maruf AA & O’Brien PJ. (2014). Flutamide-Induced Cytotoxicity and Oxidative Stress in an In Vitro Rat Hepatocyte System. Oxidative Medicine and Cellular Longevity, Vol. 2014, Article ID 398285. PubMed ID: 25371773.
13. Maruf AA, Wan L & O’Brien PJ. (2014). Evaluation of Azathioprine-Induced Cytotoxicity in an In Vitro Rat Hepatocyte System. BioMed Research International, Vol. 2014, Article ID 379748. PubMed ID: 25101277.
12. McAllister SL*, Maruf AA*, Wan L, Chung E & O’Brien PJ. (2013). Modeling Xenobiotic Susceptibility to Hepatotoxicity Using an In Vitro Oxidative Stress Inflammation Model. Canadian Journal of Physiology and Pharmacology, 91(3):236-40. *Co-first author. PubMed ID: 23537437.
11. Hassan R, Ameena SS, Maruf AA, Nandini A, Tabin H, Ahmed MU, Islam MS, Sayeed MSB & Hasnat A. (2013). Genotype-Phenotype Variability in Human CYP3A Locus in Nepalese People Residing in Bangladesh. International Journal of Clinical Pharmacology and Therapeutics, 51(3):207-14. PubMed ID: 23320986.
10. Islam MS, Ahmed MU, Bin Sayeed MS, Maruf AA, Mostofa AGM, Hussain SMA, Kabir Y, Daly AK & Hasnat A. (2012). Lung Cancer Risk in Relation to Nicotinic Acetylcholine Receptor, CYP2A6 and CYP1A1 Genotype in Bangladeshi Population. Clinica Chimica Acta, 416:11-9. PubMed ID: 23178447.
9. Maruf AA, Ahmed MU, Azad MAK, Ahmed M & Hasnat A. (2012). CYP3A Genotypes in Bangladeshi Tuberculosis Patients. Bangladesh Medical Research Council Bulletin, 38(1):1-5. PubMed ID: 22545342.
8. Maruf AA, Ahmed MU, Yasmin H, Ullah MA, Azad MAK, Daly AK & Hasnat A. (2011). Genotypes and Phenotypes of CYP3A in Bangladeshi Population. Clinica Chimica Acta, 412(7-8): 531-536. PubMed ID: 21114969.
7. Mannan SJ, Azad MA, Ullah M, Maruf AA, Rayhan I, Ahsan MS & Hasnat A. (2011). Investigation of Serum Trace Element, Malondialdehyde and Immune Status in Drug Abuser Patients Undergoing Detoxification. Biological Trace Element Research, 140(3):272-83. PubMed ID: 20390377.
6. Islam MS, Trini AB, Shohag MH, Ahmed MU, Maruf AA & Hasnat A. (2011). Comparative Bioavailability Study of Omeprazole 20 mg Capsule Encapsulated with Omeprazole 22.5% Enteric Coated Pellets with Reference Product in Healthy Bangladeshi Male Subjects: An Open-Label, Single-Dose, Randomized-Sequence, Two-Way Crossover Study. International Journal of Clinical Pharmacology and Therapeutics, 49(12):778-86. PubMed ID: 22122821.
5. Chowdhury MM, Ullah MA, Iqbal N, Maruf AA, Shohag MH, Harun S, Akter KA, Begum B, Latif AHMM & Hasnat A. (2011). Relative Bioavailability and Pharmacokinetic Study of Two Trimetazidine Modified Release Formulations in Healthy Bangladeshi Male Volunteers. Arzneimittelforschung-Drug Research, 61(7):393-8. PubMed ID: 21899207.
4. Sultana TA, Islam MS, Bhuiyan MHU, Shohag MH, Ahmed MU, Naznin SR, Maruf AA, Huq SM & Hasnat A. (2011). Comparative Pharmacokinetic and Relative Bioavailability Study of Coated and Uncoated Azithromycin Powder for Suspension in Healthy Bangladeshi Male Volunteers. Arzneimittelforschung-Drug Research, 61(10):594-8. PubMed ID: 22164968.
3. Shahed GM, Ullah MA, Maruf AA, Ahmed MU, Islam MS, Nahar Z & Hasnat A. (2011). A Simple RP−HPLC Method for the Determination of Cefdinir in Human Serum: Validation and Application in a Pharmacokinetic Study with healthy Bangladeshi Male Volunteers. Dhaka University Journal of Pharmaceutical Sciences, 10(2):109-116. View.
2. Ullah MA, Dowla SU, Maruf AA, Sultana R, Azad MAK, Shohag MD, Latif AHMM & Hasnat A. (2010). Pharmacokinetics, 2. Bioequivalence and Tolerability Study of Two Different Enteric Formulations of Esomeprazole in Healthy Bangladeshi Male Volunteers: An Open Label, Single-Dose, Randomized, Two-Way Crossover Study. Clinical Therapeutics, 32(7):1419-1426. PubMed ID: 20678688.
1. Haider N, Islam MS, Maruf AA, Shohag MH, Ali R, Rahman GKMM & Hasnat A. (2010). Oxidative Stress and Antioxidant Status in Vitiligo Patients. Dhaka University Journal of Pharmaceutical Sciences, 9(2):103-108. View.
2024
38. Maruf AA, Meagan H, Wondrasek A, Fryza A, Leong C, Kowalec K & Bousman CA. (2024). Knowledge of and Perceptions Toward Pharmacogenomics among Pharmacists in Manitoba, Canada. Pharmacogenomics. PubMed ID: 38506345.
37. Wondrasek A, Fryza A, Aziz MA, Leong C, Kowalec K, Maruf AA. (2024). Knowledge, Perceptions, and Attitudes toward Pharmacogenomics among Pharmacists and Pharmacy Students: A Systematic Review. Health Science Reports. 7(1): e1844. PubMed ID:10809028.
36. Gerlach S, Maruf AA, Shaheen S-M, McCloud R, Heintz M, McAusland L, Arnold PD & Bousman CA. (2024). Effect of CYP2D6 Genetic Variation on Patient-Reported Symptom Improvement and Side Effects among Children and Adolescents Treated with Amphetamines. Pharmacogenetics and Genomics. PubMed ID: 38517706.
35. McAusland L, Burton CL, Bagnell A, Boylan K, Hatchard T, Lingley-Pottie P, Maruf AA, McGrath P, Newton AS, Rowa K, Schachar RJ, Shaheen S-M, Stewart S, Arnold PD, Crosbie J, Mattheisen M, Soreni N, Stewart SE & Meier S (2024). The genetic architecture of youth anxiety: a study protocol. BMC Psychiatry. 24(1):159. PubMed ID:38395805.
34. Bharthi K, Zuberi R, Maruf AA, Shaheen S-M, McCloud R, Heintz M, McAusland L, Arnold PD & Bousman CA. (2024). Impact of Cytochrome P450 Genetic Variation on Patient-reported Symptom Improvement and Side Effects among Children and Adolescents Treated with Fluoxetine. Journal of Child and Adolescent Psychopharmacology. 34(1):21-27. Pubmed ID: 38377520.
2023
33. Maruf AA & Aziz MA. (2023). The Potential Roles of Pharmacists in the Clinical Implementation of Pharmacogenomics. Pharmacy (Basel). 11(6): 180. PubMed ID: 37987390.
32. Jafrin S, Aziz MA, Sajal M, Akter T, Das C, Akter T, Hussain MS, Millat MS, Uddin MS, Naznin NE, Reza MS, Maruf AA, Baeesa SS, Ashraf GM & Islam MS. (2023). ZNF804A intronic variant rs1344706 and NGRN rs12807809 genetic polymorphisms and risk of schizophrenia in Bangladesh. Human Gene. 36: 201175. Link.
31. Bousman CA, Maruf AA, Marques DF, Brown LC, Mueller DJ. (2023). Emergence, Implementation, and Future Growth of Pharmacogenomics in Psychiatry: A Narrative Review. Psychological Medicine, Sep 29;1-11. PubMed ID: 37772416.
30. Mostaid MS, Aziz MA, Maisha JA, Islam MS & Maruf AA. (2023). A Review of Pharmacogenetic Studies in the Bangladeshi Population. Drug Metabolism and Personalized Therapy, 38(2):123–131. PubMed ID: 36854045.
2022
29. Brown LC, Stanton JD, Bharthi k, Maruf AA, Müller DJ & Bousman CA. (2022). Pharmacogenomic Testing and Depressive Symptom Remission: A Systematic Review and Meta-Analysis of Prospective, Controlled Clinical Trials. Clinical Pharmacology & Therapeutics, 112(6):1303–1317. PubMed ID: 36111494.
28. Maruf AA & Bousman CA. (2022). Approaches and Hurdles of Implementing Pharmacogenetic Testing in Mental Health Care. Psychiatry and Clinical Neurosciences Reports. 1(2):e26. Pubmed ID: 38868642.
2021
27. Jessel CD, Maruf AA, Oomen A, Arnold PD & Bousman CA. (2021). Pharmacogenetic Testing Knowledge and Attitudes among Pediatric Psychiatrists and Pediatricians in Alberta, Canada. The Journal of the Canadian Academy of Child and Adolescent Psychiatry. 31(1):18-27. PubMed ID: 35251193.
26. Stein K, Maruf AA, Müller DJ, Bishop JR & Bousman CA. (2021). Serotonin Transporter Genetic Variation and Antidepressant Response and Tolerability: A Systematic Review and Meta-Analysis. Journal of Personalized Medicine. 11(12), 1334. PubMed ID: 34945806.
25. Maruf AA, Poweleit EAB, Brown LC, Strawn JR & Bousman CA. (2021). Systematic Review and Meta-Analysis of L-methylfolate Augmentation in Depressive Disorders. Pharmacospychiatry, 55(3):139-147. PubMed ID: 34794190.
2020
24. Maruf AA, Stein K, Arnold PD, Aitchison K, Müller DJ & Bousman C. (2020). CYP2D6 and Antipsychotic Treatment Outcomes in Children and Youth: A Systematic Review. Journal of Child and Adolescent Psychopharmacology. 31(1):33-45. PubMed ID: 33074724.
23. Liu C, Maruf AA & Bousman C. (2020). Reporting of Clozapine-Induced Gastrointestinal Hypomotility and Factors Associated with Fatal Outcomes in Canada. Psychiatry Research. 290:113048. PubMed ID: 32474068.
22. Maruf AA, Fan M, Arnold PD, Müller DJ, Aitchison K & Bousman C. (2020). Reply to Dawes and Colleagues. Canadian Journal of Psychiatry. PubMed ID: 32425056.
21. Maruf AA, Fan M, Arnold P, Müller DJ, Aitchison K & Bousman C. (2020). Review of Pharmacogenetic Testing Options Relevant to Psychiatry in Canada. Canadian Journal of Psychiatry. Feb 17:706743720904820. PubMed ID: 32064906.
2019
20. Maruf AA, Greenslade A, Arnold PD & Bousman C. (2019). Antidepressant Pharmacogenetics in Children and Adolescent: A Systematic Review. Journal of Affective Disorder. 254:98-108. *Co-first author. PubMed ID: 31112844.
19. Bousman CA, Maruf AA & Müller DJ. (2019). Towards The Integration of Pharmacogenetics in Psychiatry: A Minimum, Evidence-Based Genetic Testing Panel. Current Opinion in Psychiatry, 32(1):7-15. PubMed ID: 30299306.
2010 - 2018
18. Maruf AA, O’Brien PJ, Naserzadeh P, Fathian R, Salimi A & Pourahmad J. (2018). Methotrexate Induced Mitochondrial Injury and Cytochrome C Release in Rat Liver Hepatocytes. Drug and Chemical Toxicology, 16:1-11. Pubmed ID: 28298149.
17. Zhang T, Mu Y, Yang M, Maruf AA, Li Pi, Li C, Dai S, Lu J & Dong Q. (2017). (+)-Catechin Prevents Methylglyoxal-Induced Mitochondrial Dysfunction and Apoptosis in EA.hy926 Cells. Archives Of Physiology and Biochemistry, 22:1-7. PubMed ID: 28005432.
16. Maruf AA, Lip H, Wong H & O’Brien PJ. (2015). Protective Effects of Ferulic Acid and Related Polyphenols against Glyoxal- or Methylglyoxal-Induced Cytotoxicity and Oxidative Stress in Isolated Rat Hepatocytes. Chemico-Biological Interactions, 234:96-104. PubMed ID: 255446858.
15. Ng CS, Hasnat A, Maruf AA, Ahmed MU, Pirmohamed M, Day CP, Aithal GP & Daly AK. (2014). N-acetyltransferase 2 (NAT2) Genotype as a Risk Factor for Development of Drug-Induced Liver Injury Relating to Antituberculosis Drug Treatment in a Mixed-Ethnicity Patient Group. European Journal of Clinical Pharmacology, 70(9):1079-86. PubMed ID: 24888881.
14. Maruf AA & O’Brien PJ. (2014). Flutamide-Induced Cytotoxicity and Oxidative Stress in an In Vitro Rat Hepatocyte System. Oxidative Medicine and Cellular Longevity, Vol. 2014, Article ID 398285. PubMed ID: 25371773.
13. Maruf AA, Wan L & O’Brien PJ. (2014). Evaluation of Azathioprine-Induced Cytotoxicity in an In Vitro Rat Hepatocyte System. BioMed Research International, Vol. 2014, Article ID 379748. PubMed ID: 25101277.
12. McAllister SL*, Maruf AA*, Wan L, Chung E & O’Brien PJ. (2013). Modeling Xenobiotic Susceptibility to Hepatotoxicity Using an In Vitro Oxidative Stress Inflammation Model. Canadian Journal of Physiology and Pharmacology, 91(3):236-40. *Co-first author. PubMed ID: 23537437.
11. Hassan R, Ameena SS, Maruf AA, Nandini A, Tabin H, Ahmed MU, Islam MS, Sayeed MSB & Hasnat A. (2013). Genotype-Phenotype Variability in Human CYP3A Locus in Nepalese People Residing in Bangladesh. International Journal of Clinical Pharmacology and Therapeutics, 51(3):207-14. PubMed ID: 23320986.
10. Islam MS, Ahmed MU, Bin Sayeed MS, Maruf AA, Mostofa AGM, Hussain SMA, Kabir Y, Daly AK & Hasnat A. (2012). Lung Cancer Risk in Relation to Nicotinic Acetylcholine Receptor, CYP2A6 and CYP1A1 Genotype in Bangladeshi Population. Clinica Chimica Acta, 416:11-9. PubMed ID: 23178447.
9. Maruf AA, Ahmed MU, Azad MAK, Ahmed M & Hasnat A. (2012). CYP3A Genotypes in Bangladeshi Tuberculosis Patients. Bangladesh Medical Research Council Bulletin, 38(1):1-5. PubMed ID: 22545342.
8. Maruf AA, Ahmed MU, Yasmin H, Ullah MA, Azad MAK, Daly AK & Hasnat A. (2011). Genotypes and Phenotypes of CYP3A in Bangladeshi Population. Clinica Chimica Acta, 412(7-8): 531-536. PubMed ID: 21114969.
7. Mannan SJ, Azad MA, Ullah M, Maruf AA, Rayhan I, Ahsan MS & Hasnat A. (2011). Investigation of Serum Trace Element, Malondialdehyde and Immune Status in Drug Abuser Patients Undergoing Detoxification. Biological Trace Element Research, 140(3):272-83. PubMed ID: 20390377.
6. Islam MS, Trini AB, Shohag MH, Ahmed MU, Maruf AA & Hasnat A. (2011). Comparative Bioavailability Study of Omeprazole 20 mg Capsule Encapsulated with Omeprazole 22.5% Enteric Coated Pellets with Reference Product in Healthy Bangladeshi Male Subjects: An Open-Label, Single-Dose, Randomized-Sequence, Two-Way Crossover Study. International Journal of Clinical Pharmacology and Therapeutics, 49(12):778-86. PubMed ID: 22122821.
5. Chowdhury MM, Ullah MA, Iqbal N, Maruf AA, Shohag MH, Harun S, Akter KA, Begum B, Latif AHMM & Hasnat A. (2011). Relative Bioavailability and Pharmacokinetic Study of Two Trimetazidine Modified Release Formulations in Healthy Bangladeshi Male Volunteers. Arzneimittelforschung-Drug Research, 61(7):393-8. PubMed ID: 21899207.
4. Sultana TA, Islam MS, Bhuiyan MHU, Shohag MH, Ahmed MU, Naznin SR, Maruf AA, Huq SM & Hasnat A. (2011). Comparative Pharmacokinetic and Relative Bioavailability Study of Coated and Uncoated Azithromycin Powder for Suspension in Healthy Bangladeshi Male Volunteers. Arzneimittelforschung-Drug Research, 61(10):594-8. PubMed ID: 22164968.
3. Shahed GM, Ullah MA, Maruf AA, Ahmed MU, Islam MS, Nahar Z & Hasnat A. (2011). A Simple RP−HPLC Method for the Determination of Cefdinir in Human Serum: Validation and Application in a Pharmacokinetic Study with healthy Bangladeshi Male Volunteers. Dhaka University Journal of Pharmaceutical Sciences, 10(2):109-116. View.
2. Ullah MA, Dowla SU, Maruf AA, Sultana R, Azad MAK, Shohag MD, Latif AHMM & Hasnat A. (2010). Pharmacokinetics, 2. Bioequivalence and Tolerability Study of Two Different Enteric Formulations of Esomeprazole in Healthy Bangladeshi Male Volunteers: An Open Label, Single-Dose, Randomized, Two-Way Crossover Study. Clinical Therapeutics, 32(7):1419-1426. PubMed ID: 20678688.
1. Haider N, Islam MS, Maruf AA, Shohag MH, Ali R, Rahman GKMM & Hasnat A. (2010). Oxidative Stress and Antioxidant Status in Vitiligo Patients. Dhaka University Journal of Pharmaceutical Sciences, 9(2):103-108. View.